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Background: The purpose of this study is to compare the ability of the Global Activity Limitation Indicator (GALI)
and self-rated health (SRH) to predict all-cause mortality in the general adult population.
Methods: We linked the 2001 Belgian Health Interview Survey with mortality and migration registers 2001–2010.
The baseline sample included 8,583 individuals aged 15 years and older. Poisson regression models were used to
estimate the effect of the GALI and SRH on mortality rate during follow-up. We investigated the impact of gender,
age, education and follow-up period on the association between the GALI/SRH and mortality.
Results: The GALI and SRH were strong and complementary predictors of mortality in the Belgian adult population.
Although the two global instruments shared some traits, they predicted mortality concurrently, with some indication of
a somewhat stronger effect for SRH. We found neither significant differences between men and women, nor between
education groups. The predictive effect of the GALI and SRH slightly decreased over time and the predictive effect of
SRH slightly decreased with age.
Conclusions: Our findings suggest that the GALI and SRH are useful and complementary measures for assessing the
health and functional status of adults in population surveys.
Keywords: GALI, Self-rated health, Global indicator, Disability, Socioeconomic status, Mortality, Predictive ability, Healthy
Life Years, Health ExpectancyBackground
The Global Activity Limitation Indicator (GALI) refers
to a single-item measure of functional status where indi-
viduals are asked to rate their long-term limitations in
usual activities due to a health problem [1-3]. This com-
prehensive instrument is the underlying measure of the
European indicator ‘Healthy Life Years’ and is used to-
gether with self-rated health (SRH) and a chronic
morbidity question – the set of 3 questions defines the
Minimum European Health Module [2] – to monitor
population health and functioning in the European
Union [4-7]. Despite its simplicity, SRH is a powerful
instrument as it has been shown to be highly predictive
for mortality in different subgroups of the population* Correspondence: hvanoyen@wiv-isp.be
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unless otherwise stated.and in different cultures [8-12]. Attempts have been
made to understand whether the subjective assessment
of health status is associated with mortality in a similar
manner in different population subgroups, with lately
particular attention on the moderating influence of
socioeconomic status. Whereas the predictive ability of
SRH for mortality appears to weaken for females in most
settings, studies investigating the moderating influence
of socioeconomic status have shown mixed results, leav-
ing uncertainty about the measurement equivalence of
the instrument across population subgroups [11,13-17].
As opposed to SRH, the predictive power of the GALI
on mortality remains relatively unexplored. Since the
GALI was first used to calculate the European indicator
‘Healthy Life Years’ in 2004 [5], several national and
cross-national studies have shown its content validity,
showing that the global item correlates with detailed
instruments of functioning and disability in a similarThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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studies suggested that both the GALI and SRH are good
predictors of mortality in Belgium and Europe [21,22].
The predictive ability of the two items partly overlapped
in these studies; yet each measure had its own impact
on mortality. These results were expected because the
GALI and SRH aim to capture separate dimensions: the
GALI mainly measures functioning while SRH focusses
on health status [19]. The studies did not allow to deter-
mine whether gender, age, and/or socioeconomic status
modify the effect of the GALI on mortality. They reached
opposed conclusions regarding the role of gender, whereas
the influence of age and socioeconomic status have not
been explored to date. Current findings are also restricted
to short follow-up periods (2–3 years) and to older pop-
ulations (50+ and 65+). It is therefore unclear whether
the GALI has a predictive power on long-term mortality
and in the larger adult population. Noteworthy data
shortcomings – substantial attrition problems in the
first study [22] and the absence of the exact date of
death in the second [21] – further restrict the generalis-
ability of these first findings.
The objective of our study is to investigate and com-
pare the predictive ability of the GALI and SRH on mor-
tality in the Belgian adult population combining a
national survey of the adult population (15+) with a long
period of mortality follow-up (10 years). We expect the
two measures to complement each other to predict mor-
tality because the GALI and SRH focus on different
health aspects. To be a useful global instrument, the
GALI should have an added predictive value over SRH.
Our study also aims to investigate how gender, age
and socioeconomic status moderate the relationship
between mortality and both global measures, and to




Data are drawn from the 2001 Belgian Health Interview
Survey (HIS). The 2001 HIS is a national survey in
which 12,111 individuals living in Belgium were inter-
viewed [23]. The survey was carried out by Statistics
Belgium and exempt from ethics approval by law. Par-
ticipants were selected from the National Register using
a multistage sampling procedure. Household response
rate was 61.3%. The GALI and SRH questions were part
of the self-administered questionnaire restricted to indi-
viduals aged 15 years and older. Vital and migration
status of the participants were followed up: records of
the survey were linked to the National Register using a
unique identifier present in both data sources. After the
approval of the Belgian Commission for the protection
of privacy, we obtained a mortality and emigrationfollow-up of HIS participants until 31 December 2010
(approximately 10 years). The linkage was successful for
97% of the records. The final HIS sample included 8,583
individuals aged 15 years and older, of whom 902 died
and 132 emigrated. Emigrants were considered as lost
to follow-up at the date of emigration.
Measures
Age was obtained from the National Register and was
categorised into four groups: persons aged 15–49 (refer-
ence category), persons aged 50–64, persons aged 65–74
and persons aged 75 or more. Given their low probability
of death, participants aged 15–49 were grouped in a single
category. Sensitivity analysis ensured that the age group
cut-offs did not affect the results. Other variables, apart
from mortality, were drawn from the baseline question-
naire in 2001. Education was measured using the high-
est education level achieved within the household. We
recoded this measure into four categories: primary edu-
cation level or lower, lower secondary, higher second-
ary, and higher education [24].
Activity limitation was assessed with the GALI question:
‘For the past 6 months or more, have you been limited in
activities people usually do because of a health problem?
Yes, strongly limited/Yes, limited/No, not limited’ [2].
Within the ICF framework [25], the GALI corresponds to
the societal perspective of functioning, i.e. the perform-
ance of roles and social involvement in activities. The
reference to ‘activities people usually do’ fosters normative
comparisons and allows to account for differences in per-
formance of roles by age, gender, environmental and living
conditions. SRH was measured on a five-point scale, based
on the question: ‘How is your health in general?’ [26]. To
ease comparison with the GALI, we recoded SRH into
three categories: (very) bad, fair, and (very) good.
Statistical methods
We used Poisson regression models to estimate the
effect of the GALI and SRH on the mortality rate during
the follow-up period [27]. The first model (Model 1)
estimates Mortality Rates Ratios (MRRs) for sociodemo-
graphic variables alone. Model 2 and Model 3 estimate
MRRs for the GALI and SRH separately, while adjusting
for sociodemographic factors. Variants of these models
additionally estimate interaction effects between gender,
age and education and each measure of ill health (results
not reproduced). The full model (Model 4) includes all
predictors (without interactions), allowing to compare
the relative predictive ability of the GALI and SRH. For
significant moderators, stratum-specific estimates of the
GALI and SRH are presented for each value of the
sociodemographic moderator. The impact of the follow-
up period was assessed by comparing MRRs at different
times of the follow-up, adjusting for all covariates. We
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adjust the relationship between the GALI or SRH and
mortality because we aimed to assess the importance of
the GALI compared to SRH as predictors of mortality.
Adjusting for other health and functioning measures
would affect the GALI and SRH unequally and prevent
rigorous comparison between the two global instru-
ments [19]. All analyses were conducted using Stata 12
(StataCorp, College Station, USA).Results
22.20% of respondents reported a long-term activity
limitation and 25.04% reported a fair or bad health at
the interview (Table 1). Men, respondents with a lower
education level, and older individuals had a higher mor-
tality rate. Mortality rate also increased as the level of ill
health increased: mortality rate was about 4 times higher
(=26.38/6.31) for individuals with moderate activity limi-
tations and more than 9 times higher (=60.02/6.31) for
those with severe limitations, as compared to individuals
without limitations. For SRH, mortality rate ratios (MRRs)Table 1 Characteristics of the 2001 Belgian Health
Interview Survey sample and mortality rate (per 1,000






15-49 58.28 72 1.54
50-64 21.88 159 9.37
65-74 11.81 262 31.01
75 or higher 8.03 409 88.37
Gender
Men 48.81 508 13.72
Women 51.19 394 9.90
Education
Primary 15.54 342 30.94
Lower secondary 19.11 222 15.27
Higher secondary 30.32 196 8.24
Tertiary 35.03 142 5.17
Activity limitations (GALI)
No limitation 77.80 387 6.31
Moderate limitation 17.15 327 26.38
Severe limitation 5.04 188 60.02
Self-rated health (SRH)
(Very) good 74.96 367 6.21
Fair 20.62 367 24.40
(Very) bad 4.42 168 61.49were very comparable to those of the GALI (i.e. 3.93
(=24.40/6.21) and 9.90 (=61.49/6.21), for those reporting
SRH as fair or (very) bad respectively).
When adjusting for sociodemographic predictors of
mortality (age, gender and education), MRRs decreased
for both the GALI and SRH, but remained significant
(Table 2). In a global model including the GALI, SRH
and other covariates (Model 4), both measures had a sig-
nificant effect on mortality. Moderate activity limitations
and fair health both increased mortality rates by almost
1.5. The effect of severe limitations was slightly higher
(MRR = 1.79) whereas the effect of (very) bad health was
the strongest (MRR = 2.50). Although the crude MRRs
were similar for the GALI and SRH, the predictive power
of very bad SRH on mortality was slightly higher after
adjustment.
The predictive ability of the GALI and SRH for mor-
tality did not vary with gender or with education (re-
sults not shown). Yet, age moderated the effect of SRH
on mortality (significant interaction). As age increased,
the predictive ability on mortality of both fair and
(very) bad health decreased (Table 3). The MRR of fair
health decreased from 2.89 to 1.24 from the youngest
age group (15–49) to the oldest (75+) and the MRR of
(very) bad health decreased from 4.82 to 1.74. Despite
this trend, there is evidence that SRH predicted mortal-
ity in all age groups (with weaker evidence for fair
health in population older than 75 years). Age did not
affect the GALI in the same manner. Even though age-
specific effects of the GALI on mortality slightly varied
(Table 3), no clear pattern emerged and there was no
significant interaction between age and the GALI.
There was not enough evidence for a significant effect
of the GALI in the youngest age group (due to the
modest estimated effects and the low number of
deaths). Moderate limitations in particular seemed to
have little or no impact on mortality in individuals
younger than 65 years. Comparison between the GALI
and SRH indicates that the mortality impact of the
GALI seemed lower in the younger age group and of
similar magnitude in the older age group, as compared
to SRH.
The length of follow-up did not appear to play a large
role in the findings. We estimated models that restricted
the time of follow-up to 0–3 years, 3–6 years and 6–10
years and found significant effects on mortality in all
periods (p < 0.05) (Table 4). Yet, overall the impacts of
the GALI and SRH decreased over time. For instance,
the effect of severe limitations decreased from 2.82
(in the first 3 years of follow-up) to 1.49 (in the last
period). The effect of moderate limitations and fair health
evolved in a similar fashion with a slight decrease in the
MRR as the length of follow-up increased. It appears
however that the MRR of (very) bad health was less
Table 2 Mortality rate ratios* (and 95% CI) of the GALI, SRH, gender and education during 10-year follow-up, 2001
Belgian Health Interview Survey
Model 1 Model 2 Model 3 Model 4
(Sociodemographics) (Sociodemographics + GALI) (Sociodemographics + SRH) (Sociodemographics +
GALI + SRH)
Age
15-49 (ref cat) 1.00 1.00 1.00 1.00
50-64 5.61 5.11 5.02 4.92
(4.24-7.41) (3.86-6.76) (3.79-6.64) (3.79-6.52)
65-74 17.21 14.19 14.22 13.54
(13.20-22.45) (10.84-18.58) (10.86-18.61) (10.34-17.75)
75 or higher 49.80 37.23 38.84 35.72
(38.51-64.40) (28.59-48.49) (29.89-50.46) (27.42-46.55)
Gender
Men (ref cat) 1.00 1.00 1.00 1.00
Women 0.57 0.55 0.54 0.54
(0.50-0.65) (0.48-0.63) (0.47-0.61) (0.47-0.61)
Education
Primary 1.98 1.74 1.63 1.61
(1.62-2.43) (1.42-2.13) (1.33-2.01) (1.32-1.98)
Lower secondary 1.59 1.49 1.43 1.43
(1.29-1.97) (1.21-1.85) (1.16-1.78) (1.15-1.77)
Higher secondary 1.31 1.32 1.25 1.28
(1.05-1.62) (1.06-1.61) (1.01-1.56) (1.03-1.59)
Tertiary (ref cat) 1.00 1.00 1.00 1.00
Activity limitations (GALI)
No limitation (ref cat) 1.00 1.00
Moderate limitation 1.77 1.37
(1.52-2.06) (1.16-1.63)
Severe limitation 2.96 1.79
(2.46-3.56) (1.42-2.25)
Self-rated health (SRH)
(Very) good (ref cat) 1.00 1.00
Fair 1.78 1.49
(1.53-2.07) (1.26-1.77)
(Very) bad 3.63 2.50
(3.00-4.39) (1.97-3.18)
log likelihood −2711.73 −2644.65 −2629.60 −2616.87
*: from a Poisson regression model.
CI Confidence interval; GALI global activity limitation indicator; SRH self-rated health.
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from 3.32 to 2.20 midway through follow-up and
slightly increased to 2.62 in the last period of follow-up.
Although the MRRs of having severe limitations and be-
ing in (very) bad health were higher compared to the
MRRs of having moderate limitations and being in fair
health, respectively, the difference was only statistically
significant for SRH in the last period of follow-up.Discussion
This study shows that the Global Activity Limitation In-
dicator and self-rated health are strong and complemen-
tary predictors of mortality in the Belgian adult
population. Although the two indicators share some
characteristics, they predict mortality concurrently, with
some indications of a somewhat stronger effect for SRH.
There were neither significant differences between men
Table 3 Mortality rate ratios* (and 95% CI) of the GALI and SRH by age group, 2001 Belgian Health Interview Survey
15-49 50-64 65-74 75+
Activity limitations (GALI)
No limitation (ref cat) 1.00 1.00 1.00 1.00
Moderate limitation 1.00 (0.48-2.06) 1.25 (0.82-1.92) 1.42 (1.03-1.96) 1.33 (1.04-1.69)
Severe limitation 2.00 (0.77-5.21) 2.52 (1.44-4.40) 1.77 (1.16-2.70) 1.69 (1.22-2.33)
Self-rated health (SRH)
(Very) good (ref cat) 1.00 1.00 1.00 1.00
Fair 2.89 (1.58-5.26) 1.93 (1.28-2.92) 1.38 (1.01-1.90) 1.24 (0.97-1.58)
(Very) bad 4.82 (1.77-13.12) 4.03 (2.24-7.25) 2.80 (1.82-4.30) 1.74 (1.23-2.45)
*: from a Poisson regression model adjusted for gender, education and the other health measure.
CI Confidence interval; GALI global activity limitation indicator; SRH self-rated health.
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ive ability of SRH appeared to slightly decrease with age.
The effect of the global measures on mortality slightly
decreased over time; yet we found that moderate limita-
tions and fair health still allowed to predict mortality
after more than 6 years of follow-up. Severe limitations
had a slightly stronger effect, while the effect of (very)
bad health remained strong towards the end of the
follow-up.
Using – for the first time – a long (10 years) and
accurate (97% of successful linkage) mortality follow-up
we showed that the GALI is a complementary predictor
of mortality to SRH in the whole adult population of
Belgium. Two previous studies that examined this issue
have reported an independent effect of the GALI on
mortality in the older population in Europe and Belgium,
respectively. The first study used the Survey of Health,
Ageing and Retirement in Europe (SHARE) to estimate
the mortality impact of the GALI and SRH in the
presence of other health covariates [22]. The design of
that study did not allow to compare the predictive power
of the two global indicators because other covariates of
the model overlapped the health dimensions captured by
the GALI and SRH unequally. Yet, the study concluded




No limitation (ref cat) 1.00
Moderate limitation 1.56 (1.05-2.33)
Severe limitation 2.82 (1.77-4.50)
Self-rated health (SRH)
(Very) good (ref cat) 1.00
Fair 1.82 (1.23-2.70)
(Very) bad 3.32 (2.03-5.42)
*: from a Poisson regression model adjusted for age, gender, education and the oth
CI Confidence interval; GALI global activity limitation indicator; SRH self-rated healthwas, to a great extent, independent of SRH. The second
study directly compared the GALI and SRH and con-
cluded that the GALI was as strong as SRH (and stronger
in women) for predicting mortality in the Belgian older
population [21]. In the current analysis we found that
SRH had a slightly higher predictive power (although there
was no significant difference between GALI and SRH
estimates), which decreased with age. Our results indi-
cate that in the older population, the GALI and SRH
seem to have similar predictive ability for mortality,
which partly corroborates the earlier study.
The fact that we did not find gender differences in the
predictive ability of the GALI for mortality is consistent
with the Belgian study of the older population mentioned
above [21]. In the SHARE study, the model excluding
other health covariates also found similar estimates for
males and females, although estimates were significant for
women only in the model including additional health
variables [22]. In a similar fashion, we found no gender
differences for the effect of SRH on mortality, which is
consistent with studies carried out in Sweden [13] and
the United Kingdom [28].
This study also explored whether education modified
the association between the GALI and mortality. The
predictive powers of the GALI and SRH were consistentRH by period of follow-up, 2001 Belgian Health Interview
3-6 years 6-10 years
1.00 1.00
1.46 (1.08-1.97) 1.29 (1.00-1.66)
1.70 (1.13-2.56) 1.49 (1.04-2.13)
1.00 1.00
1.69 (1.26-2.26) 1.29 (1.01-1.65)
2.20 (1.43-3.39) 2.62 (1.81-3.78)
er health measure.
.
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study which showed that the GALI was neither influ-
enced by gender nor by social class, after controlling for
other functional status variables [19]. Results are also in
line with Swedish and English studies that found no
moderating effect of socioeconomic status in the rela-
tionship between SRH and mortality [13,16].
Overall, the associations between the two global mea-
sures and mortality were invariant to sociodemographic
variables included in our study, with the exception of
age for SRH. Such results suggest that the GALI, and to
a lower extent SRH, provide comparable information
across population subgroups. This reinforces the rele-
vance of global measures of health for assessing health
and functioning. Further research is needed to confirm
our findings in different settings. Further research
should also investigate the answering behaviour for the
GALI question and the processes by which respondents
adapt their answers depending on their sociodemo-
graphic and cultural settings. It would be particularly
relevant to understand to what extent these processes
differ between the GALI and SRH with respect to age.
Our analysis has several strengths: we were able to use
one large national survey which contained health and
mortality data; more than 97% of the survey participants
could be linked to the National Register to obtain the
exact date of death and emigration (loss to follow-up);
and the length of the follow-up (10 years) allowed to
differentiate short-term from long-term effects of the
GALI and SRH on mortality.
There is an important limitation related to the findings
reported here. The response rate of the Belgian Health
Interview Survey (61.30%) and the underrepresentation
of institutionalised populations may bias the results [29].
Previous studies showed that participation in the survey
depends on health status and socioeconomic position
[30,31]. Mortality rates based on survey follow-up tend
to be underestimated, but not to the same extent across
all education groups. A recent study showed that lowly
educated participants in the 2001 Belgian Health Inter-
view Survey tend to be less healthy (i.e. having a higher
probability of dying during the follow-up) compared to
their counterparts in the general population [32]. This
could partly explain why we also found a strong predict-
ive power of the GALI and SRH on mortality in lowly
educated participants.
Another shortcoming of the study is that we did not
assess the added value of the GALI and SRH for predicting
mortality in comparison with more detailed (objective and
self-reported) measures of health and functioning. The
main objective of the study was to compare the predictive
ability of the GALI and SRH on mortality. As the GALI
and SRH cover different constructs and given the broad
conceptual reach of SRH, we did not include measures ofmental and physical health, functional limitations or
activities of daily living. Such an adjustment would have
affected the GALI and SRH unequally and prevented
rigorous comparison between the two global items [19].
Further studies should therefore investigate the added
value of the GALI for predicting mortality in the pres-
ence of objective and/or subjective measures of func-
tional status.
Conclusions
This study has shown that the global activity limitation
indicator and self-rated health are powerful predictors of
mortality in Belgium in different age and socioeconomic
groups, among men and among women and over time.
The results suggest that the two single-item instruments
are useful and complementary measures for assessing
the health and functional status of adults in health and
non-health surveys.
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